In health tech, the gap between AI winners and laggards isn't about technology. It's about strategy.
As ambient clinical intelligence becomes table stakes, health tech leaders face a new challenge: how do you translate AI ambition into meaningful clinical and business impact? Health tech companies are racing to build clinical AI in-house without a clear business strategy, a path to clinician adoption, or a view of what end-users actually need. Pilots stall. Roadmaps drift. Competitive advantage never materializes.
Join Suki and a panel of health tech leaders for a candid discussion on what separates organizations moving beyond pilots from those still stuck in experimentation. As ambient clinical intelligence evolves beyond documentation into decision support and care management, what are clinicians actually demanding? And how should product, strategy, and innovation leaders think about building versus partnering for capabilities that are advancing faster than most roadmaps can keep up with?
Whether you’re shaping product strategy, evaluating AI investments, or defining your organization’s next competitive advantage, this session will leave you rethinking your AI strategy and ready to act.